Global Gastrointestinal OTC Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drugs Therapeutic Class;

Gastric Acid Reducers, Gastric Acid Neutralizers, Laxatives, Anti-diarrheals, Anti-emetics and Others.

Segmented by Indication;

Heartburn, Constipation, Diarrhea, Nausea due to motion sickness and Flatulence.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn609632593 Published Date: March, 2024 Updated Date: April, 2024

Introduction

Global Gastrointestinal OTC Drugs Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 81.6
2021 87.0
2022 88.3
2023 88.6
2024 94.7
2025 100.4
2026 103.0
2027 103.8
2028 112.7
2029 131.9
2030 152.1

In the year 2023, the Global Gastrointestinal OTC Drugs Market was valued at USD 40,527.84 million. The size of this market is expected to increase to USD 55,910.89 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drugs Therapeutic Class
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Gastrointestinal OTC Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Gastrointestinal OTC Drugs Market, By Drugs Therapeutic Class, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Gastric Acid Reducers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Gastric Acid Neutralizers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Laxatives
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Anti-diarrheals
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Anti-emetics
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Gastrointestinal OTC Drugs Market, By Indication, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Heartburn
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Constipation
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Diarrhea
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Nausea due to motion sickness
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Flatulence
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Gastrointestinal OTC Drugs Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Therapeutic Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Bayer
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. GlaxoSmithKline
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Johnson & Johnson
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Perrigo
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Pfizer
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Procter & Gamble
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Gastroparesis Drug
Global Gastroparesis Drug Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Gastroparesis Drug Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Gaucher Disease Drugs
Global Gaucher Disease Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Gaucher Disease Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Gaucher Disease
Global Gaucher Disease Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Gaucher Disease Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Gauze Bandage Rolls
Global Gauze Bandage Rolls Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Gauze Bandage Rolls Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...